<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medecol</journal-id><journal-title-group><journal-title xml:lang="ru">Медицина и экология</journal-title><trans-title-group xml:lang="en"><trans-title>Medicine and ecology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-6045</issn><issn pub-type="epub">2305-6053</issn><publisher><publisher-name>Карагандинский медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.59598/ME-2305-6053-2025-116-3-35-47</article-id><article-id custom-type="elpub" pub-id-type="custom">medecol-1036</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEWS</subject></subj-group></article-categories><title-group><article-title>Распространенность различных этиопатогенетических вариантов хронических диффузных заболеваний печени</article-title><trans-title-group xml:lang="en"><trans-title>PREVALENCE OF VARIOUS ETIOPATHOGENIC VARIANTS OF CHRONIC DIFFUSE LIVER DISEASES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сахова</surname><given-names>Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Sakhova</surname><given-names>B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Базаркуль Сахова </p><p>161200, г. Туркестан, пр. Б. Саттарханова</p></bio><bio xml:lang="en"><p>Bazarkul Sakhova </p><p>161200, Turkestan city, B. Sattarkhanov Avenue, 29</p></bio><email xlink:type="simple">bazarkul.sahova@ayu.edu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ошибаева</surname><given-names>А.</given-names></name><name name-style="western" xml:lang="en"><surname>Oshibayeva</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>161200, г. Туркестан, пр. Б. Саттарханова</p></bio><bio xml:lang="en"><p>161200, Turkestan city, B. Sattarkhanov Avenue, 29</p></bio><email xlink:type="simple">info@ayu.edu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нұсқабаева</surname><given-names>Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nuskabayeva</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>161200, г. Туркестан, пр. Б. Саттарханова</p></bio><bio xml:lang="en"><p>161200, Turkestan city, B. Sattarkhanov Avenue, 29</p></bio><email xlink:type="simple">info@ayu.edu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Искандирова</surname><given-names>Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Iskandirova</surname><given-names>E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>161200, г. Туркестан, пр. Б. Саттарханова</p></bio><bio xml:lang="en"><p>161200, Turkestan city, B. Sattarkhanov Avenue, 29</p></bio><email xlink:type="simple">info@ayu.edu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рсалиева</surname><given-names>Ж.</given-names></name><name name-style="western" xml:lang="en"><surname>Rsalieva</surname><given-names>Zh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>160013, г. Шымкент, ул. Жандосова, 52</p></bio><bio xml:lang="en"><p>160013, Shymkent city, Zhandosov str., 52</p></bio><email xlink:type="simple">shgmb17@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карабаев</surname><given-names>Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Karabayev</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>160013, г. Шымкент, ул. Жандосова, 52</p></bio><bio xml:lang="en"><p>160013, Shymkent city, Zhandosov str., 52</p></bio><email xlink:type="simple">shgmb17@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каримова</surname><given-names>Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Karimova</surname><given-names>L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>161200, г. Туркестан, пр. Б. Саттарханова</p></bio><bio xml:lang="en"><p>161200, Turkestan city, B. Sattarkhanov Avenue, 29</p></bio><email xlink:type="simple">info@ayu.edu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Озбакыр</surname><given-names>Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Ozbakyr</surname><given-names>L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>161200, г. Туркестан, пр. Б. Саттарханова</p></bio><bio xml:lang="en"><p>161200, Turkestan city, B. Sattarkhanov Avenue, 29</p></bio><email xlink:type="simple">info@ayu.edu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Международный казахско-турецкий университет имени Ходжи Ахмета Ясави<country>Казахстан</country></aff><aff xml:lang="en">International Kazakh-Turkish University named after Khoja Ahmet Yasawi<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Городская больница №2<country>Казахстан</country></aff><aff xml:lang="en">City hospital No. 2<country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2025</year></pub-date><volume>0</volume><issue>3</issue><fpage>35</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сахова Б., Ошибаева А., Нұсқабаева Н., Искандирова Э., Рсалиева Ж., Карабаев Н., Каримова Л., Озбакыр Л., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Сахова Б., Ошибаева А., Нұсқабаева Н., Искандирова Э., Рсалиева Ж., Карабаев Н., Каримова Л., Озбакыр Л.</copyright-holder><copyright-holder xml:lang="en">Sakhova B., Oshibayeva A., Nuskabayeva N., Iskandirova E., Rsalieva Z., Karabayev N., Karimova L., Ozbakyr L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medecol.qmu.kz/jour/article/view/1036">https://medecol.qmu.kz/jour/article/view/1036</self-uri><abstract><p>Хронические диффузные заболевания печени (ХДЗП) – собирательное понятие, объединяющее различные по этиологии заболевания, сопровождающиеся развитием диффузного поражения печеночной паренхимы, которое характеризуется отклонением от нормы биохимических маркеров функции печени и продолжается более 6 месяцев.</p><p>В последние десятилетия ХДЗП являются предметом активного изучения гепатологов и пристального внимания со стороны практикующих врачей. Прежде всего, это связано с тем, что распространенность заболеваний печени с каждым годом возрастает во всем мире, причем наиболее часто данная патология развивается у лиц трудоспособного возраста, значительно снижая качество их жизни. Данные современной литературы свидетельствуют, что в настоящее время хронические заболевания печени занимают существенное место среди причин ранней нетрудоспособности и смертности населения.</p><p>По данным Всемирной организации здравоохранения, за последние 20 лет наблюдается неуклонный рост заболеваний печени как вирусной, так и невирусной этиологии. В среднем в мире насчитывается более 2 млрд человек, страдающих ХДЗП, что в 100 раз превышает распространенность ВИЧ-инфекции. При этом основным контингентом больных становится, как правило, трудоспособная, социально активная часть населения. ХДЗП включают широкий спектр нозологически самостоятельных воспалительных заболеваний различной этиологии.</p><p>Таким образом, поражения печени различной этиологии происходят примерно в одной и той же последовательности, называемой «печеночный континуум», конечным звеном которого является ГЦК. Поэтому не только эффективная терапия и меры профилактики развития самих ХДЗП, но и возможность продуктивно вмешаться в данный континуум в настоящее время являются одной из наиболее актуальных проблем современной гепатологии.</p><p>Принимая во внимание скудность эпидемиологических данных из регионов Азии, Африки и Латинской Америки, и отсутствия согласованности в региональных и возрастных закономерностях распространённости хронических диффузных заболеваний печени, требуются дальнейшие исследования для выявления глобального бремени заболевания.</p><p>Целью данного обзора являлся поиск литературных данных распространенности различных по этиопатогенезу диффузных инфильтративных и воспалительных заболеваний печени.</p><p>Для достижения поставленной цели проанализированы публикации зарубежных авторов в базах данных Scopus и Pubmed. С учетом глубины поиска – последние 10 лет, языка публикации – русский, английский, в анализ включено 38 полнотекстных статей.</p></abstract><trans-abstract xml:lang="en"><p>Chronic diffuse liver diseases (CDLD) is a collective concept that unites diseases of various etiologies, accompanied by the development of diffuse damage to the liver parenchyma, which is characterized by deviations from the norm in biochemical markers of liver function and lasts more than 6 months.</p><p>In recent decades, CDPD has been the subject of active study by hepatologists and close attention from practicing physicians. First of all, this is due to the fact that the prevalence of liver diseases is increasing every year all over the world, and most often this pathology develops in people of working age, significantly reducing their quality of life.</p><p>Data from modern literature indicate that currently chronic liver diseases occupy a significant place among the causes of early disability and mortality of the population.</p><p>On average, there are more than 2 billion people worldwide suffering from chronic diffuse liver disease (CDLD), which is 100 times higher than the prevalence of HIV infection. In this case, the main contingent of patients becomes, as a rule, the able-bodied, socially active part of the population. CDPD include a wide range of nosologically independent inflammatory diseases of various etiologies</p><p>Thus, liver lesions of various etiologies occur in approximately the same sequence, called the “liver continuum”, the final link of which is HCC. Therefore, not only effective therapy and measures to prevent the development of CDPD themselves, but also the ability to productively intervene in this continuum are currently one of the most pressing problems of modern hepatology.</p><p>Given the paucity of epidemiological data from regions of Asia, Africa and Latin America, and the lack of consistency in regional and age-specific patterns of prevalence of chronic diffuse liver disease, further research is required to identify the global burden of the disease.</p><p>The purpose of this review was to search for literature data on the prevalence of diffuse infiltrative and inflammatory liver diseases of various etiopathogenesis.</p><p>To achieve this goal, publications of foreign authors in the Scopus and Pubmed databases were analyzed. Taking into account the depth of the search - the last 10 years, the language of publication - Russian, English, 38 full-text articles were included in the analysis</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хронические диффузные заболевания печени</kwd><kwd>цирроз</kwd><kwd>МАЖБП</kwd><kwd>вирусные гепатиты</kwd><kwd>аутоиммунный гепатит</kwd><kwd>первичный склерозирующий холангит</kwd><kwd>алкогольное поражение печени</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic diffuse liver diseases</kwd><kwd>cirrhosis</kwd><kwd>MAFLD</kwd><kwd>viral hepatitis</kwd><kwd>autoimmune hepatitis</kwd><kwd>primary sclerosing cholangitis</kwd><kwd>alcoholic liver damage</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Aimin W., Bin F., Jie Y., Lijun Y., Lianqiang C., Yong Zh., Yuheng L., Bing Y., De W., Daiwen C. Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biology. 2021; 46: 102131. https://doi.org/10.1016/j.redox.2021.102131</mixed-citation><mixed-citation xml:lang="en">Aimin W., Bin F., Jie Y., Lijun Y., Lianqiang C., Yong Zh., Yuheng L., Bing Y., De W., Daiwen C. Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biology. 2021; 46: 102131. https://doi.org/10.1016/j.redox.2021.102131</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Alberts C.J., Clifford G.M., Georges D., Negro F., Lesi O.A., Hutin Y.J., de Martel C. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol. Hepatol. 2022; 7 (8): 724-735. https://doi.org/10.1016/S2468-1253(22)00050-4</mixed-citation><mixed-citation xml:lang="en">Alberts C.J., Clifford G.M., Georges D., Negro F., Lesi O.A., Hutin Y.J., de Martel C. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol. Hepatol. 2022; 7 (8): 724-735. https://doi.org/10.1016/S2468-1253(22)00050-4</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Allison R., Guraka A., Shawa I. T., Tripathi G., Moritz W., Kermanizadeh A. Drug induced liver injury – a 2023 update. Journal of Toxicology and Environmental Health. 2023; 26 (8): 442-467. https://doi.org/10.1080/10937404.2023.2261848</mixed-citation><mixed-citation xml:lang="en">Allison R., Guraka A., Shawa I. T., Tripathi G., Moritz W., Kermanizadeh A. Drug induced liver injury – a 2023 update. Journal of Toxicology and Environmental Health. 2023; 26 (8): 442-467. https://doi.org/10.1080/10937404.2023.2261848</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Aslam A., Kwo P.Y. Epidemiology and Disease Burden of Alcohol Associated Liver Disease. J. Clin. Exp. Hepatol. 2023; 13 (1): 88-102. https://doi.org/10.1016/j.jceh.2022.09.001</mixed-citation><mixed-citation xml:lang="en">Aslam A., Kwo P.Y. Epidemiology and Disease Burden of Alcohol Associated Liver Disease. J. Clin. Exp. Hepatol. 2023; 13 (1): 88-102. https://doi.org/10.1016/j.jceh.2022.09.001</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Björnsson E.S. The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update. Pharmaceuticals (Basel). 2024; 17 (4): 520. https://doi.org/10.3390/ph17040520 PMID: 38675480</mixed-citation><mixed-citation xml:lang="en">Björnsson E.S. The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update. Pharmaceuticals (Basel). 2024; 17 (4): 520. https://doi.org/10.3390/ph17040520 PMID: 38675480</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bril F., Al Diffalha S., Dean M., Fettig D.M. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty? J. Hepatol. 2021; 75 (1): 222-224. https://doi.org/10.1016/j.jhep.2021.04.003</mixed-citation><mixed-citation xml:lang="en">Bril F., Al Diffalha S., Dean M., Fettig D.M. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty? J. Hepatol. 2021; 75 (1): 222-224. https://doi.org/10.1016/j.jhep.2021.04.003</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Burke L., Hinkson A., Haghnejad V., Jones R., Parker R., Rowe I. A. Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and metaanalysis. JHEP Rep. 2024; 7 (1): 101227. https://doi.org/10.1016/j.jhepr.2024.101227</mixed-citation><mixed-citation xml:lang="en">Burke L., Hinkson A., Haghnejad V., Jones R., Parker R., Rowe I. A. Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and metaanalysis. JHEP Rep. 2024; 7 (1): 101227. https://doi.org/10.1016/j.jhepr.2024.101227</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cao G., Jing W., Liu J., Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol. Int. 2021; 15 (5): 1068-1082. https://doi.org/10.1007/s12072-021-10232-4</mixed-citation><mixed-citation xml:lang="en">Cao G., Jing W., Liu J., Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol. Int. 2021; 15 (5): 1068-1082. https://doi.org/10.1007/s12072-021-10232-4</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Stephens C., Robles-Diaz M., Medina-Caliz I., Garcia-Cortes M., Ortega-Alonso A., Sanabria-Cabrera J., Gonzalez-Jimenez A., Alvarez-Alvarez I., Slim M., Jimenez-Perez M., Gonzalez-Grande R., Fernández M.C., Casado M., Soriano G., Román E., Hallal H., Romero-Gomez M., Castiella A., Conde I., Prieto M., Moreno-Planas J.M., Giraldez A., Moreno-Sanfiel J.M., Kaplowitz N., Lucena M.I., Andrade R.J. Participating clinical centres. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J. Hepatol. 2021; 75 (1): 86-97. https://doi.org/10.1016/j.jhep.2021.01.029</mixed-citation><mixed-citation xml:lang="en">Stephens C., Robles-Diaz M., Medina-Caliz I., Garcia-Cortes M., Ortega-Alonso A., Sanabria-Cabrera J., Gonzalez-Jimenez A., Alvarez-Alvarez I., Slim M., Jimenez-Perez M., Gonzalez-Grande R., Fernández M.C., Casado M., Soriano G., Román E., Hallal H., Romero-Gomez M., Castiella A., Conde I., Prieto M., Moreno-Planas J.M., Giraldez A., Moreno-Sanfiel J.M., Kaplowitz N., Lucena M.I., Andrade R.J. Participating clinical centres. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J. Hepatol. 2021; 75 (1): 86-97. https://doi.org/10.1016/j.jhep.2021.01.029</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper J., Markovinovic A., Coward S., Herauf M., Shaheen A.A., Swain M., Panaccione R., Ma C., Lu C., Novak K., Kroeker K.I., Ng S.C., Kaplan G.G. Incidence and Prevalence of Primary Sclerosing Cholangitis: A Metaanalysis of Population-based Studies. Inflamm. Bowel. Dis. 2024; 30 (11): 2019-2026. https://doi.org/10.1093/ibd/izad276</mixed-citation><mixed-citation xml:lang="en">Cooper J., Markovinovic A., Coward S., Herauf M., Shaheen A.A., Swain M., Panaccione R., Ma C., Lu C., Novak K., Kroeker K.I., Ng S.C., Kaplan G.G. Incidence and Prevalence of Primary Sclerosing Cholangitis: A Metaanalysis of Population-based Studies. Inflamm. Bowel. Dis. 2024; 30 (11): 2019-2026. https://doi.org/10.1093/ibd/izad276</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Devarbhavi H., Asrani S.K., Arab J.P., Nartey Y.A., Pose E., Kamath P.S. Global burden of liver disease: 2023 update. J. Hepatol. 2023; 79 (2): 516-537. https://doi.org/10.1016/j.jhep.2023.03.017</mixed-citation><mixed-citation xml:lang="en">Devarbhavi H., Asrani S.K., Arab J.P., Nartey Y.A., Pose E., Kamath P.S. Global burden of liver disease: 2023 update. J. Hepatol. 2023; 79 (2): 516-537. https://doi.org/10.1016/j.jhep.2023.03.017</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Miravitlles M., Herepath M., Priyendu A., Sharma Sh., Vilchez T., Vit O., Haensel M., Lepage V., Gens H., Greulich T. Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews European Respiratory Review. 2022; 31 (163): 210-262. https://doi.org/10.1183/16000617.0262-2021</mixed-citation><mixed-citation xml:lang="en">Miravitlles M., Herepath M., Priyendu A., Sharma Sh., Vilchez T., Vit O., Haensel M., Lepage V., Gens H., Greulich T. Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews European Respiratory Review. 2022; 31 (163): 210-262. https://doi.org/10.1183/16000617.0262-2021</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 2020; 5 (3): 245-266. https://doi.org/10.1016/S2468-1253(19)30349-8</mixed-citation><mixed-citation xml:lang="en">GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 2020; 5 (3): 245-266. https://doi.org/10.1016/S2468-1253(19)30349-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Niu X., Zhu L., Xu Y. Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis. BMC Public Health. 2023; 23: 859. https://doi.org/10.1186/s12889-023-15749-x</mixed-citation><mixed-citation xml:lang="en">Niu X., Zhu L., Xu Y. Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis. BMC Public Health. 2023; 23: 859. https://doi.org/10.1186/s12889-023-15749-x</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Griffin C., Agbim U., Ramani A., Shankar N., Kanwal F., Asrani S.K. Underestimation of Cirrhosis-Related Mortality in the Medicare Eligible Population, 19992018. Clin. Gastroenterol. Hepatol. 2023; 21 (1): 223-225. https://doi.org/10.1016/j.cgh.2021.10.036</mixed-citation><mixed-citation xml:lang="en">Griffin C., Agbim U., Ramani A., Shankar N., Kanwal F., Asrani S.K. Underestimation of Cirrhosis-Related Mortality in the Medicare Eligible Population, 19992018. Clin. Gastroenterol. Hepatol. 2023; 21 (1): 223-225. https://doi.org/10.1016/j.cgh.2021.10.036</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hahn J.W., Yang H.R., Moon J.S., Chang J.Y., Lee K., Kim G.A., Rahmati M., Koyanagi A., Smith L., Kim M.S., López Sánchez G.F., Elena D., Shin J.Y., Shin J.I., Kwon R., Kim S., Kim H.J., Lee H., Ko J.S., Yon D.K. Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and metaanalysis. EClinicalMedicine. 2023; 65: 102280. https://doi.org/10.1016/j.eclinm.2023.102280</mixed-citation><mixed-citation xml:lang="en">Hahn J.W., Yang H.R., Moon J.S., Chang J.Y., Lee K., Kim G.A., Rahmati M., Koyanagi A., Smith L., Kim M.S., López Sánchez G.F., Elena D., Shin J.Y., Shin J.I., Kwon R., Kim S., Kim H.J., Lee H., Ko J.S., Yon D.K. Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and metaanalysis. EClinicalMedicine. 2023; 65: 102280. https://doi.org/10.1016/j.eclinm.2023.102280</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Han S., Yang Z., Zhang T., Ma J., Chandler K., Liangpunsakul S. Epidemiology of Alcohol-Associated Liver Disease. Clin. Liver Dis. 2021; 25 (3): 483-492. https://doi.org/10.1016/j.cld.2021.03.009</mixed-citation><mixed-citation xml:lang="en">Han S., Yang Z., Zhang T., Ma J., Chandler K., Liangpunsakul S. Epidemiology of Alcohol-Associated Liver Disease. Clin. Liver Dis. 2021; 25 (3): 483-492. https://doi.org/10.1016/j.cld.2021.03.009</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024: 242.</mixed-citation><mixed-citation xml:lang="en">Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024: 242.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Huang D.Q., Mathurin P., Cortez-Pinto H., Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat. Rev. Gastroenterol. Hepatol. 2023; 20 (1): 37-49. https://doi.org/10.1038/s41575-022-00688-6</mixed-citation><mixed-citation xml:lang="en">Huang D.Q., Mathurin P., Cortez-Pinto H., Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat. Rev. Gastroenterol. Hepatol. 2023; 20 (1): 37-49. https://doi.org/10.1038/s41575-022-00688-6</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ke L., Lu C., Shen R., Lu T., Ma B., Hua Y. Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019). Front Pharmacol. 2020; 11: 842. https://doi.org/10.3389/fphar.2020.00842</mixed-citation><mixed-citation xml:lang="en">Ke L., Lu C., Shen R., Lu T., Ma B., Hua Y. Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019). Front Pharmacol. 2020; 11: 842. https://doi.org/10.3389/fphar.2020.00842</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H.Y., Yu J.H., Chon Y.E., Kim S.U., Kim M.N., Han J.W., Lee H.A., Jin Y.J., An J., Choi M., Jun D.W. Prevalence of clinically significant liver fibrosis in the general population: A systematic review and metaanalysis. Clin. Mol. Hepatol. 2024; 30: 199-213. https://doi.org/10.3350/cmh.2024.0351</mixed-citation><mixed-citation xml:lang="en">Kim H.Y., Yu J.H., Chon Y.E., Kim S.U., Kim M.N., Han J.W., Lee H.A., Jin Y.J., An J., Choi M., Jun D.W. Prevalence of clinically significant liver fibrosis in the general population: A systematic review and metaanalysis. Clin. Mol. Hepatol. 2024; 30: 199-213. https://doi.org/10.3350/cmh.2024.0351</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Li P., Liu J., Li Y., Su J., Ma Z., Bramer W.M., Cao W., de Man R.A., Peppelenbosch M.P., Pan Q. The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis. Liver Int. 2020; 40 (7): 1516-1528. https://doi.org/10.1111/liv.14468</mixed-citation><mixed-citation xml:lang="en">Li P., Liu J., Li Y., Su J., Ma Z., Bramer W.M., Cao W., de Man R.A., Peppelenbosch M.P., Pan Q. The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis. Liver Int. 2020; 40 (7): 1516-1528. https://doi.org/10.1111/liv.14468</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Low E., Zheng Q., Chan E., Lim S. Drug induced liver injury: East versus West – a systematic review and meta-analysis. Clin. Mol. Hepatol. 2020; 26: 142-154. https://doi.org/10.3350/cmh.2019.1003</mixed-citation><mixed-citation xml:lang="en">Low E., Zheng Q., Chan E., Lim S. Drug induced liver injury: East versus West – a systematic review and meta-analysis. Clin. Mol. Hepatol. 2020; 26: 142-154. https://doi.org/10.3350/cmh.2019.1003</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell E.L., Khan Z. Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions. Curr. Pathobiol. Rep. 2018; 6 (1): 97. https://doi.org/10.1007/s40139-018-0164-z</mixed-citation><mixed-citation xml:lang="en">Mitchell E.L., Khan Z. Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions. Curr. Pathobiol. Rep. 2018; 6 (1): 97. https://doi.org/10.1007/s40139-018-0164-z</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hakim M.S., Wang W., Bramer W.M., Geng J., Huang F., de Man, R.A., Peppelenbosch M.P., Pan Q. The global burden of hepatitis E outbreaks: a systematic review. Liver Int. 2017; 37: 19-31. https://doi.org/10.1111/liv.13237</mixed-citation><mixed-citation xml:lang="en">Hakim M.S., Wang W., Bramer W.M., Geng J., Huang F., de Man, R.A., Peppelenbosch M.P., Pan Q. The global burden of hepatitis E outbreaks: a systematic review. Liver Int. 2017; 37: 19-31. https://doi.org/10.1111/liv.13237</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017; 390 (10113): 2627-2642. https://doi.org/10.1016/S0140-6736(17)32129-3</mixed-citation><mixed-citation xml:lang="en">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017; 390 (10113): 2627-2642. https://doi.org/10.1016/S0140-6736(17)32129-3</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ovchinnikova E.V., Garbuz M.M., Ovchinnikova A.A., Kumeiko V.V. Epidemiology of Wilson's Disease and Pathogenic Variants of the ATP7B Gene Leading to Diversified Protein Disfunctions. Int. J. Mol. Sci. 2024; 25 (4): 2402. https://doi.org/10.3390/ijms25042402</mixed-citation><mixed-citation xml:lang="en">Ovchinnikova E.V., Garbuz M.M., Ovchinnikova A.A., Kumeiko V.V. Epidemiology of Wilson's Disease and Pathogenic Variants of the ATP7B Gene Leading to Diversified Protein Disfunctions. Int. J. Mol. Sci. 2024; 25 (4): 2402. https://doi.org/10.3390/ijms25042402</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Patel E.U., Thio C.L., Boon D., Thomas D.L., Tobian A.A.R. Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016. Clin. Infect. Dis. 2019; 69 (4): 709-712. https://doi.org/10.1093/cid/ciz001</mixed-citation><mixed-citation xml:lang="en">Patel E.U., Thio C.L., Boon D., Thomas D.L., Tobian A.A.R. Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016. Clin. Infect. Dis. 2019; 69 (4): 709-712. https://doi.org/10.1093/cid/ciz001</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Porter J.L., Rawla P. Hemochromatosis. [Updated 2024 Oct 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430862/</mixed-citation><mixed-citation xml:lang="en">Porter J.L., Rawla P. Hemochromatosis. [Updated 2024 Oct 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430862/</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Sato-Espinoza K., Chotiprasidhi P., Liza E., Placido-Damian Z., Diaz-Ferrer J. Evolution of liver transplantation in the metabolic dysfunction-associated steatotic liver disease era: Tracking impact through time. World J. Transplant. 2024; 14 (4): 98718. https://doi.org/10.5500/wjt.v14.i4.98718</mixed-citation><mixed-citation xml:lang="en">Sato-Espinoza K., Chotiprasidhi P., Liza E., Placido-Damian Z., Diaz-Ferrer J. Evolution of liver transplantation in the metabolic dysfunction-associated steatotic liver disease era: Tracking impact through time. World J. Transplant. 2024; 14 (4): 98718. https://doi.org/10.5500/wjt.v14.i4.98718</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Shen Z.X., Wu D.D., Xia J., Wang X.B., Zheng X., Huang Y., Li B.L., Meng Z.J., Gao Y.H., Qian Z.P., Liu F., Lu X.B., Shang J., Yan H.D., Zheng Y.B., Gu W.Y., Zhang Y., Liu C.Y., Yuan W., Mei X., Li J., Li T., Zhou X.Y., Deng G.H., Chen J.J., Ma X., Li H. Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China. World J. Gastroenterol. 2022; 28 (31): 4417-4430. https://doi.org/10.3748/wjg.v28.i31.4417</mixed-citation><mixed-citation xml:lang="en">Shen Z.X., Wu D.D., Xia J., Wang X.B., Zheng X., Huang Y., Li B.L., Meng Z.J., Gao Y.H., Qian Z.P., Liu F., Lu X.B., Shang J., Yan H.D., Zheng Y.B., Gu W.Y., Zhang Y., Liu C.Y., Yuan W., Mei X., Li J., Li T., Zhou X.Y., Deng G.H., Chen J.J., Ma X., Li H. Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China. World J. Gastroenterol. 2022; 28 (31): 4417-4430. https://doi.org/10.3748/wjg.v28.i31.4417</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Stockdale A.J., Kreuels B., Henrion M.Y.R., Giorgi E., Kyomuhangi I., de Martel C., Hutin Y., Geretti A.M. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J. Hepatol. 2020; 73 (3): 523-532. https://doi.org/10.1016/j.jhep.2020.04.008</mixed-citation><mixed-citation xml:lang="en">Stockdale A.J., Kreuels B., Henrion M.Y.R., Giorgi E., Kyomuhangi I., de Martel C., Hutin Y., Geretti A.M. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J. Hepatol. 2020; 73 (3): 523-532. https://doi.org/10.1016/j.jhep.2020.04.008</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Younossi Z.M., Wong G., Anstee Q.M., Henry L. The Global Burden of Liver Disease. Clinical Gastroenterology and Hepatology. 2023; 21: 1978-1991. https://doi.org/10.1016/j.cgh.2023.04.015</mixed-citation><mixed-citation xml:lang="en">Younossi Z.M., Wong G., Anstee Q.M., Henry L. The Global Burden of Liver Disease. Clinical Gastroenterology and Hepatology. 2023; 21: 1978-1991. https://doi.org/10.1016/j.cgh.2023.04.015</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Weisman M.H., Stens O., Seok K.H, Hou J.K., Miller F.W., Dillon C.F. Inflammatory Bowel Disease Prevalence: Surveillance data from the U.S. National Health and Nutrition Examination Survey. Prev. Med. Rep. 2023; 33: 102173. https://doi.org/10.1016/j.pmedr.2023.102173</mixed-citation><mixed-citation xml:lang="en">Weisman M.H., Stens O., Seok K.H, Hou J.K., Miller F.W., Dillon C.F. Inflammatory Bowel Disease Prevalence: Surveillance data from the U.S. National Health and Nutrition Examination Survey. Prev. Med. Rep. 2023; 33: 102173. https://doi.org/10.1016/j.pmedr.2023.102173</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Wongtrakul W., Niltwat S., Charatcharoenwitthaya N., Karaketklang K., Charatcharoenwitthaya P. Global prevalence of advanced fibrosis in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J. Gastroenterol. Hepatol. 2024; 39 (11): 2299-2307. https://doi.org/10.1111/jgh.16666</mixed-citation><mixed-citation xml:lang="en">Wongtrakul W., Niltwat S., Charatcharoenwitthaya N., Karaketklang K., Charatcharoenwitthaya P. Global prevalence of advanced fibrosis in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J. Gastroenterol. Hepatol. 2024; 39 (11): 2299-2307. https://doi.org/10.1111/jgh.16666</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018: 472.</mixed-citation><mixed-citation xml:lang="en">Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018: 472.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Younossi Z.M., Golabi P., Paik J.M., Henry A., Van Dongen C., Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023; 77 (4): 1335-1347. https://doi.org/10.1097/HEP.0000000000000004</mixed-citation><mixed-citation xml:lang="en">Younossi Z.M., Golabi P., Paik J.M., Henry A., Van Dongen C., Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023; 77 (4): 1335-1347. https://doi.org/10.1097/HEP.0000000000000004</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y.B., Chen M.K. Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions. World J. Gastroenterol. 2022; 28 (41): 5910-5930. https://doi.org/10.3748/wjg.v28.i41.5910</mixed-citation><mixed-citation xml:lang="en">Liu Y.B., Chen M.K. Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions. World J. Gastroenterol. 2022; 28 (41): 5910-5930. https://doi.org/10.3748/wjg.v28.i41.5910</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
